Boron tribromide → HCID 22144534, compound

HRID 1824808Notes

Reaction equation

[Br:1][C:2]1[C:7]2[N:8]=[C:9]([C:11]3[CH:16]=[CH:15][CH:14]=[C:13]([O:17]C)[C:12]=3[CH:19]([CH3:21])[CH3:20])[S:10][C:6]=2[CH:5]=[C:4]([O:22]C)[CH:3]=1.B(Br)(Br)Br>>[Br:1][C:2]1[C:7]2[N:8]=[C:9]([C:11]3[CH:16]=[CH:15][CH:14]=[C:13]([OH:17])[C:12]=3[CH:19]([CH3:20])[CH3:21])[S:10][C:6]=2[CH:5]=[C:4]([OH:22])[CH:3]=1

Participants

Reactant 2

HCID 25134Boron tribromide

HCID 22144559HCID 22144559, compound

Product 1

HCID 22144534HCID 22144534, compoundYield 54%

Procedure

4-Bromo-6-methoxy-2-(2-isopropyl-3-methoxy-phenyl)-benzothiazole (60 mg, 0.153 mmol) was treated with boron tribromide under standard condition to give the title compound (30 mg, 54% yield) as a yellow solid. Mass spec: MH+=364.

Sources & evidence

ORD record: ord-ab63a002813e4a6e85fb2ad67f4c3c1b
Source dataset: uspto-grants-2006_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07045539B2

Reaction notes

Loading…